Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A Phase III Transition Study of DRL Rituximab to Reference Medicinal Products

ClinicalTrials.gov ID: NCT04268771

Public ClinicalTrials.gov record NCT04268771. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 6, 2026, 8:43 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-blind, Parallel Group, Multicenter Study to Assess the Immunogenicity and Safety of Transitioning Subjects With Rheumatoid Arthritis to Biosimilar Rituximab (DRL_RI) or Continued Treatment With Rituxan® or MabThera®

Study identification

NCT ID
NCT04268771
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Dr. Reddy's Laboratories Limited
Industry
Enrollment
140 participants

Conditions and interventions

Interventions

  • Arm B: Rituxan®/Mabthera® Biological
  • Experimental: Arm A: DRL_RI Biological

Biological

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 7, 2020
Primary completion
Jan 25, 2022
Completion
Apr 19, 2022
Last update posted
Nov 17, 2023

2020 – 2022

United States locations

U.S. sites
26
U.S. states
11
U.S. cities
21
Facility City State ZIP Site status
Arizona Arthritis and Rheumatology Research, PLLC Phoenix Arizona 85032
California Allergy and Asthma Medical Group - CRN - PPDS 41230 11th Street West, Suite A Palmdale California 93551
Inland Rheumatology Clinical Trials Incorporated Upland California 91786
Rheumatology Consultant of Delaware dba Delaware Arthritis Lewes Delaware 19958
MedBio Trials Aventura Florida 33180
Clinical Research of West Florida Inc - Clearwater Clearwater Florida 33765
Medical Research Center Miami Florida 33144
AppleMed Research Group, LLC Miami Florida 33155
Integral Rheumatology and Immunology Specialist, 140 Southwest 84th Avenue, Suite B Plantation Florida 33324.
Vicis Clinical Research INC Tampa Florida 33615
Springfield Clinic (Clinic location) Springfield Illinois 62702
Bluegrass Community Research Inc,330 Waller Avenue, Suite 100, Lexington Kentucky 40504.
Arthritis and Osteoporosis Associates Freehold New Jersey 07728
Integrative Rheumatology Charlotte North Carolina 28210
Altoona Center For Clinical Research, 175 Meadowbrook Lane, Duncansville Pennsylvania 16635
Articularis Healthcare Group, Inc dba Low Country Rheumatology Summerville South Carolina 29486
Accurate Clinical Management, LLC Baytown Texas 77521
Trinity Clinical Research LLC, 2008 East Hebron Parkway, Suites 120/114/100, Carrollton Texas 75010
Abigail Neiman Houston Texas 77084
Accurate Clinical Management, LLC Houston Texas 77084
Laila A Hassan, MD, PA Houston Texas 77084
Accurate Clinical Research-Houston, 11003 Resource Parkway, Suite 102 Houston Texas 77089
Houston Rheumatology & Arthritis Specialists Katy Texas 77494
Clinical Associates in Research Therapeutics of America, LLC San Antonio Texas 78212
Accurate Clinical Research, Inc. San Antonio Texas 78229
Accurate Clinical Research-League City Texas City Texas 77034

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04268771, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 17, 2023 · Synced May 6, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04268771 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →